演題募集
提出締切
2023年2月14日 2023年2月28日 延長しました
提出方法
- 演題は事務局あてにメール添付にてお送りください。メール送信後、5日以内に事務局より受領通知メールをお送りします。もしも受領通知メールが届かない場合は事務局までご連絡ください。事務局メールアドレス： isid2023spp@gmail.com
- 提出後、原稿の変更は一切お受けすることができません。提出前にご確認いただけますようお願いいたします。
- 演題が採択された場合は、会場にて発表していただきますので、シンポジウムへの参加登録と参加費のお支払いが必要になります。
ガイドライン
- 文字制限：2300文字まで(タイトル、著者名、所属、演題本文、スペースを含む)。
- PDFファイルにてご提出ください。他の形式では受け付けません。
- 提出期限後、実行委員会がすべての演題を審査いたします。
- 採否通知は、2023年4月上旬にメールにてお知らせします。
- 採択された演題は、ポスター発表の形式で発表していただきます。いくつかの演題は口頭発表に選出されることがあります。ポスター発表の場合は、ポスター（紙）をポスターホールに展示しポスターセッションにご参加いただくこととなります。
Abstract outcomes
Poster Number | 1st author | Affiliation | title | outcomes |
1 | Henriette Franz | Department of Biomedicine, University of Basel, Pestalozzistrasse 20, 4056 Basel | CRISPR/Cas9 screening identified KLF5 as novel modulator of desmosomal adhesion in pemphigus | Oral & Poster |
2 | Takenobu Yamamoto | Department of Dermatology, Kawasaki Medical School, Kurashiki, Japan | Disturbed epithelial integrity protects against cell-to-cell transmission of HSV-1 in keratinocytes | Poster |
3 | Navaneetha Krishnan Bharathan | Dept of Dermatology, Penn State College of Medicine, Hershey, USA | Structure of a novel endoplasmic reticulum-desmosome complex | Oral & Poster |
4 | Nina Kokkonen | Department of Dermatology, Research Unit of Clinical Science, University of Oulu, Finland | Structural disruption of collagen XVII/BP180 decelerates the cutaneous wound closure in mice | Poster |
5 | Anna M. Sigmund | Chair of Vegetative Anatomy, Institute of Anatomy, Faculty of Medicine, LMU Munich, Germany | EPAC1 contributes to apremilast-mediated rescue of pemphigus autoantibody-induced loss of keratinocyte adhesion | Poster |
6 | Siavash Rahimi | Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Switzerland | Role of proliferation and mechanostructural signaling in pemphigus vulgaris | Poster |
7 | William V.J. Hariton | Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Switzerland | Uncoupling desmosomal cadherin adhesion activates quiescent hair follicle stem cells and orchestrates self-organized regeneration through outside-in signaling | Poster |
8 | William V.J. Hariton | Department of Dermatology, Bern University Hospital, Switzerland; Department for BioMedical Research, University of Bern, Switzerland | To enhance wound healing through non-invasive biophysical applications | Poster |
9 | Wenxiu He | Department of Oral Medicine, Peking University School and Hospital of Stomatology & National Center for Stomatology & National Clinical Research Center for Oral Diseases, Beijing, PR China | Saliva antibodies to desmoglein 3 as a diagnostic and disease monitoring marker in mucosal pemphigus vlgaris | Poster |
10 | Julia Haneberg | Chair of Vegetative Anatomy, Institute of Anatomy, Faculty of Medicine, LMU Munich, Munich, Germany | The role of PKC subtype-specific signaling in the regulation of keratinocyte adhesion in pemphigus | Poster |
11 | Roberta Lotti | DermoLAb, University of Modena and Reggio Emilia, Modena, Italy. | Blocking Fas Ligand ameliorates pemphigus: PC111 efficacy in in-vitro, ex-vivo and in-vivo human pemphigus models | Poster |
12 | Kristina Seiffert-Sinha | Dept. of Dermatology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, NY, USA | CyTOF technology reveals an HLA-dependent pro-inflammatory immunome in pemphigus through shifts in dendritic-, natural killer- and T cell compartments | Poster |
13 | Lauren Sielski | Dept. of Dermatology, University at Buffalo | Desmoglein compensation hypothesis fidelity assessment in Pemphigus | Poster |
14 | Animesh A. Sinha | Dept. of Dermatology, Jacobs School of Medicine and Biomedical Sciences, University at | Patient Genetics Shape the Autoimmune Response in Pemphigus Vulgaris | Poster |
15 | Takuya Kawamura | Department of Dermatology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University | Basophil activation and low levels of circulating basophils correlate with clinical severity in bullous pemphigoid | Poster |
16 | Joost Meijer | University of Groningen, University Medical Center Groningen, Department of Dermatology, UMCG | Gene expression profiling points to complement activation as important for blister formation in bullous pemphigoid | Poster |
17 | Shoko Mai | Department of Dermatology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan | Conformational epitope mapping of autoantibodies against BP180 in dipeptidyl peptidase-4 inhibitors-associated bullous pemphigoid | Oral & Poster |
18 | Chihiro Shiiya | Department of Dermatology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan | Aged mice produce IgM autoantibodies against the basement membrane zone | Poster |
19 | Jing Li | Division of Dermatology, Rush University Medical Center, Chicago, Illinois, USA | Afucosylated anti-IL5Rα antibody is an effective treatment in murine bullous pemphigoid-like epidermolysis bullosa | Poster |
20 | Manuela Pigors | Lübeck Institute of Experimental Dermatology; University of Lübeck, Germany | The pathogenicity of bullous pemphigoid anti-type XVII collagen C-terminal IgG is driven by complement and Fcγ receptor-mediated mechanisms | Poster |
21 | Stephanie Goletz | Lübeck Institute of Experimental Dermatology, University of Lübeck, Germany | Laminin beta4: a protein of the cutaneous basal membrane zone and autoantigen of anti-p200 pemphigoid | Oral & Poster |
22 | S. Patzelt | Lübeck Institute of Experimental Dermatology; University of Lübeck, Germany | CXCR1/2 inhibition ameliorates clinical lesions in experimental mucous membrane pemphigoid | Poster |
23 | Katja Bieber | Luebeck institute of Experimental Dermatology, University of Luebeck, Luebeck, Germany | Selective inhibition of c-Met as a novel treatment option in experimental epidermolysis bullosa acquisita | Poster |
24 | Norito ishii | Department of Dermatology, Kurume University School of Medicine, Kurume, Fukuoka, Japan, | Concomitant mucous membrane pemphigoid and dermatitis herpetiformis: Analysis of the autoimmune blistering response | Poster |
25 | Janet A. Fairley | 1University of Iowa, Iowa City, IA, USA | Design of A Phase 3 Study of Benralizumab in Bullous Pemphigoid (FJORD) | Poster |
26 | Simon D. Lytton | SeraDiaLogistics 81545 Munich, Germany | Novel Autoantigen Peptide Epitopes as Theranostic Targets in Incurable Autoimmune Blistering Diseases | Poster |
27 | Natalie Gross | Luebeck Institute of Experimental Dermatology, University of Luebeck, Luebeck, Germany | Adoptive Treg transfer ameliorates autoantibody-induced inflammation in experimental EBA | Poster |
28 | Norihiro Yoshimoto | Department of Dermatology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan | Type XVII collagen-specific CD4+ T cell clones induce bullous pemphigoid in mice by producing IL-5 | Poster |
29 | Miho Mukai | Dermatology, Keio University School of Medicine, Tokyo | A novel therapeutic strategy using stabilized antigen-specific iTreg for pemphigus | Poster |
30 | Shirin Emtenani | Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany | Characterization and pharmacological inhibition of an adult antibody-transfer mouse model of pemphigus vulgaris | Poster |
31 | Beatriz Wittlin | argenx, Ghent, Belgium | Efgartigimod: A Novel FcRn Antagonist in the Treatment of Autoimmune Diseases | Poster |
32 | Baptiste Janela | Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore | Deciphering the immune mechanism of autoreactive B cells in Pemphigus | Oral & Poster |
33 | Shohei Egami | Department of Dermatology, Keio University School of Medicine, | Desmoglein-specific B-cell-targeted single-cell analysis revealing unique gene regulation in pemphigus patients | Poster |
34 | Sho Katayama | Department of Dermatology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan | NUDT15 variants among Japanese patients with autoimmune blistering diseases: a single-center retrospective observational study | Poster |
35 | Hetal Patel | Janssen Pharmaceutical Companies of Johnson & Johnson, Horsham, PA, USA | Quality of life in patients with bullous pemphigoid | Poster |
36 | Khalaf Kridin | Azrieli Faculty of Medicine, Bar-Ilan University, Safed, ISR | A Retrospective Observational Study to Assess the Risk of Select Adverse Events of Special Interest During Oral Corticosteroid Use in Bullous Pemphigoid Patients | Poster |
37 | Päivi Leisti | Medical Research Center Oulu, Oulun yliopistollinen sairaala, Oulu, Finland | MUCOUS MEMBRANE PEMPHIGOID IS ASSOCIATED WITH MULTIPLE SOMATIC AND PSYCHIATRIC COMORBIDITIES | Poster |
38 | Outi Varpuluoma | PEDEGO Research Unit, University of Oulu, Oulu, Finland; | Solid and hematological malignancies are not associated with increased risk for bullous pemphigoid in a national cohort of 3708 patients | Poster |
39 | Nina van Beek | Department of Dermatology, Allergology and Venereology, University of Lübeck, Lübeck, Germany | Efficacy and safety of adjuvant immunoadsorption in pemphigus vulgaris and pemphigus foliaceus (IA-Pem Study): a multicentre randomised controlled trial | Poster |
40 | Calvin N. Ho | AstraZeneca, Gaithersburg, MD, USA | Qualitative Patient Interviews to Explore Health-Related Quality of Life in Patients with Bullous Pemphigoid | Poster |
41 | Nirohshah Trialonis-Suthakharan | Institute for Health Services Research in Dermatology and Nursing, University Medical Center Hamburg-Eppendorf, Hamburg, Germany | Patient-reported impact of dermatological diseases (PRIDD) measure: pemphigus and pemphigoid delphi data | Poster |